Augmentin Duo Forte Dosing for Lower Respiratory Tract Infections
For lower respiratory tract infections, the recommended dose of Augmentin Duo Forte is 875 mg/125 mg (amoxicillin/clavulanate) taken orally every 12 hours. 1
Dosing Regimen
The FDA-approved dosing for respiratory tract infections is straightforward:
- Standard dose: One 875 mg/125 mg tablet every 12 hours
- Alternative for more severe infections: One 500 mg/125 mg tablet every 8 hours 1
Both regimens are clinically equivalent. The every-12-hour dosing with the 875 mg formulation offers the advantage of improved compliance with twice-daily administration while maintaining comparable efficacy to the three-times-daily 500 mg regimen 2.
Duration of Treatment
Treatment duration typically ranges from 7-15 days depending on clinical response 1, 2. For acute exacerbations of chronic bronchitis specifically, studies have shown that even shorter courses may be effective when using higher-dose formulations 3.
Administration Considerations
Take Augmentin Duo Forte at the start of a meal to:
While the medication can be taken without regard to meals, starting with food optimizes both efficacy and tolerability.
Clinical Evidence Supporting This Dose
The 875 mg every 12 hours regimen has been validated in pivotal trials involving 1,191 patients with lower respiratory tract infections, demonstrating:
- Comparable efficacy to 500 mg every 8 hours (93% vs 94% clinical success) 1, 2
- Significantly less severe diarrhea (1.0% vs 2.5% withdrawal rate) 1
- High bacteriological success rates (97% eradication) 1
Guideline Context
European guidelines support the use of high-dose amoxicillin/clavulanate formulations (2000 mg/125 mg every 12 hours) for their ability to eradicate amoxicillin-resistant pneumococcal strains with MICs of 4-8 mg/L 4, 5. While the 875 mg formulation provides lower amoxicillin dosing than the 2000 mg formulation, it remains the standard FDA-approved "Duo Forte" dose and is effective for most community-acquired lower respiratory tract infections.
Dose Adjustments
Renal impairment:
- GFR <30 mL/min: Do NOT use the 875 mg tablet 1
- GFR 10-30 mL/min: Use 500 mg or 250 mg every 12 hours 1
- GFR <10 mL/min: Use 500 mg or 250 mg every 24 hours 1
- Hemodialysis: Additional dose during and after dialysis 1
Hepatic impairment: Dose with caution and monitor liver function regularly 1
Important Caveats
- Do NOT substitute two 250 mg tablets for one 500 mg tablet—they contain different amounts of clavulanate 1
- The 875 mg formulation demonstrated statistically significant reduction in severe diarrhea compared to more frequent dosing 1
- For severe pneumonia requiring hospitalization or ICU care, intravenous formulations and combination therapy are preferred over oral monotherapy 5